54-Year-Old with Psoriasis and Hepatitis C Virus Infection
K Darji, DJ No, M Amin, JJ Wu - 2017 - Springer
Several patients suffer from the concomitant hepatitis C virus (HCV) infection and psoriasis.
First-line treatment for patients with moderate to severe psoriasis and HCV includes …
First-line treatment for patients with moderate to severe psoriasis and HCV includes …
Fototerapia y fotoquimioterapia por ultravioletas
JC Beani - EMC-Dermatología, 2017 - Elsevier
La fototerapia se ha ido diversificando a medida que se descubrían nuevas fuentes de
ultravioletas (UV). En realidad, tuvo un primer auge con las lámparas de vapor de mercurio …
ultravioletas (UV). En realidad, tuvo un primer auge con las lámparas de vapor de mercurio …
[PDF][PDF] Psoriasis kezelése hepatitis C vírussal fertôzött betegeken* Treatment of psoriasis in patients with hepatitis C
SA DR - doki.net
With the help of a case presentation, the author would like to draw attention to the challenge
of treating psoriatic patients suffering from hepatitis C infection. Since the frequent …
of treating psoriatic patients suffering from hepatitis C infection. Since the frequent …
[PDF][PDF] ÖZEL DURUMLARDA TEDAVİ ALGORİTMALARI
EB Başkan - Türkiye Psoriasis Tedavi Kılavuzu-2016 - jag.journalagent.com
Doğurgan çağda korunmayan ve gebe kalmak isteyen kadınlarda gebelik ve laktasyon
dönemine benzer şekilde tedavi yaklaşımı önerilir. Hastaya gebelik sırasında% 10-20 …
dönemine benzer şekilde tedavi yaklaşımı önerilir. Hastaya gebelik sırasında% 10-20 …
Sind TNF-α-Hemmer eine sichere Option zur Behandlung von Psoriasis bei Patienten mit Hepatitis-C-Virus-Infektion und fortgeschrittener Lebererkrankung …
S Di Nuzzo, V Boccaletti, C Fantini, C Cortelazzi… - Kompass …, 2016 - karger.com
Inhibitoren des Tumornekrosefaktor alpha (TNF-α-Hemmer) stellen eine wirksame
Therapieoption zur Behandlung schwerer Psoriasis bei Hepatitis-C-Virus (HCV)-positiven …
Therapieoption zur Behandlung schwerer Psoriasis bei Hepatitis-C-Virus (HCV)-positiven …
Голимумаб в лечении псориатического артрита: эффективность и безопасность
ТВ Коротаева, ЕЮ Логинова - Современная ревматология, 2015 - cyberleninka.ru
Фактор некроза опухоли α (ФНОα) занимает центральное место в патогенезе
аутоиммунных воспалительных заболеваний опорно-двигательного аппарата. В …
аутоиммунных воспалительных заболеваний опорно-двигательного аппарата. В …
Golimumab in the treatment of psoriatic arthritis: efficacy and safety
TV Korotaeva, EY Loginova - Modern Rheumatology Journal, 2015 - mrj.ima-press.net
Tumor necrosis factor-α (TNF-α) holds a central position in the pathogenesis of autoimmune
inflammatory diseases of the locomotor apparatus. A separate class of drugs, namely, TNF-α …
inflammatory diseases of the locomotor apparatus. A separate class of drugs, namely, TNF-α …
[PDF][PDF] World Journal of
E Vilarrasa, L Puig - World, 2014 - researchgate.net
Patients with moderate or severe psoriasis have a high prevalence of chronic liver disease.
Chronic liver disease in these patients is related to metabolic syndrome, alcohol abuse or …
Chronic liver disease in these patients is related to metabolic syndrome, alcohol abuse or …
Adalimumab
EJ Horn, JC Cather - Advances in Psoriasis: A Multisystemic Guide, 2014 - Springer
Psoriasis is common, chronic, disease of the immune system, affecting 2–3% of the
population worldwide. Characterized by scaling, erythema, and thickened plaques on the …
population worldwide. Characterized by scaling, erythema, and thickened plaques on the …
Special Patient Populations
The diversity of psoriasis is rooted in its association with a variety of complex medical issues
and comorbid conditions. The management of psoriasis patients can be challenging …
and comorbid conditions. The management of psoriasis patients can be challenging …